The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre study.
暂无分享,去创建一个
A. Matsuda | N. Yoshida | Y. Baba | Y. Miyamoto | R. Tokunaga | M. Iwatsuki | S. Iwagami | K. Ogawa | H. Baba | Hiromichi Sonoda | Takeshi Yamada | Hiroshi Yoshida | T. Akiyama
[1] Yoosoo Chang,et al. Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study , 2019, International journal of cancer.
[2] E. Otsuji,et al. Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer , 2019, BMC Cancer.
[3] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.
[4] J. Satagopan,et al. LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response , 2018, PloS one.
[5] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[6] A. Zeitouni,et al. Neutrophil‐to‐lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta‐analysis , 2018, Head & neck.
[7] Masayoshi Yamamoto,et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] Peng Du,et al. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis , 2017, International Journal of Clinical Oncology.
[9] L. Antonuzzo,et al. Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer , 2017, British Journal of Cancer.
[10] M. Kerin,et al. The prognostic value of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review , 2017, Journal of surgical oncology.
[11] L. Holmberg,et al. Serum lactate dehydrogenase and survival following cancer diagnosis , 2015, British Journal of Cancer.
[12] A. Papavassiliou,et al. Preoperative serum lactate dehydrogenase levels in colorectal and gastric cancer: a hospital-based case-control study. , 2013, Biomarkers in medicine.
[13] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[14] H. Lenz,et al. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. , 2007, Pharmacogenomics.